Improvements in Aerobic Fitness With Exercise Training: the Role of Myokines
1 other identifier
interventional
21
1 country
1
Brief Summary
For both healthy adults and patients with cardiovascular disease (CVD), aerobic fitness (V̇O2max) is a stronger predictor of the risk of future chronic disease and premature death than other established risk factors such as hypertension, smoking, or Type 2 diabetes. It is important to improve the understanding of the regulation of V̇O2max to enable optimisation of interventions aimed at increasing V̇O2max in the current predominantly sedentary population. Currently, only exercise training is a viable method for increasing V̇O2max. However, \~10-20% of people who follow fully supervised, standardised training interventions do not demonstrate a measurable increase in V̇O2max. Low response to training is a clinically relevant concern, but the large variability in response to exercise training also provides an opportunity to dissect out the molecular mechanisms responsible for adaptations to V̇O2max by contrasting low vs. high responders to training. It has been previously demonstrated that low responders for VO2max fail to up regulate a number of genes that encode putative 'myokines', while the high responders demonstrated a significant increase in the expression of these genes, suggesting these myokines may play an important mechanistic role in modulating VO2max. The aim of the present study is to examine whether low responders for VO2max have an attenuated increase in the plasma levels of the previously identified myokines.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 23, 2023
CompletedFirst Submitted
Initial submission to the registry
November 13, 2023
CompletedFirst Posted
Study publicly available on registry
November 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedApril 29, 2026
April 1, 2026
8 months
November 13, 2023
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Training induced changes in VO2max
Maximal aerobic capacity (VO2max) will be measured pre- and post-training to determine the change in VO2max.
Pre-intervention and 3 days post-intervention
Training induced changes in plasma myokines
Plasma myokine levels of 8 myokines will be measured pre- and post-training to determine the change in plasma myokine levels.
Pre-intervention and 3 days post-intervention
Study Arms (1)
Reduced-exertion high-intensity interval training (REHIT)
EXPERIMENTALAll participants complete 6 weeks (3 sessions/week) of an exercise intervention labelled 'REHIT'. Exercise sessions involve 10 minutes of unloaded cycling interspersed with 2 x 20 sec 'all-out' sprints against a resistance of 7.5% of participant's body weight. Sprints begin at 1:40 min and 5:40 min.
Interventions
Description same as Arm description.
Eligibility Criteria
You may qualify if:
- Male
- Age ≥ 18 y or \<40 y
- BMI \< 35 kg/m2
- otherwise healthy, untrained individuals
You may not qualify if:
- Age \<18 y or \>40 y
- BMI \> 35 kg/m2
- classification of 'highly physically active' according to the International Physical Activity Questionnaire (IPAQ)
- answering 'yes' to one or more questions on a standard Physical Activity Readiness Questionnaire (PAR-Q)
- resting heart rate ≥100bpm, clinically significant hypertension (140/90 mmHg)
- a personal history of metabolic or cardiovascular disease
- Female participants because of unknown effects of the menstrual cycle on the levels of the measured myokines.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Stirling
Stirling, FK9 4LA, United Kingdom
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Niels Vollaard, PhD
University of Stirling
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 13, 2023
First Posted
November 21, 2023
Study Start
October 23, 2023
Primary Completion
June 30, 2024
Study Completion
June 1, 2025
Last Updated
April 29, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share